Cara Care has been acquired by Mahana Therapeutics
Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.
Cara Care is the leading German digestive health therapeutic solution that combines both, mental and nutritional therapy options. With its MDR Class I approved IBS solution which is fully reimbursed by all German SHI and DiGA-certified providers, the company stands as a pioneer and demonstrates growth in an underserved sector. Venture capital-backed with lead investors Atlantic Labs, Asabys Partners, Johnson & Johnson Innovation & Dr. Schar, Cara Care was able to build a product pipeline not only for IBS but also heartburn, dyspepsia and IBD.
Mahana Therapeutics is a US-based company that stands at the forefront of digital health innovation, specializing in the development of digital therapeutics for chronic health conditions. With a focus on cognitive and behavioral therapy-based solutions, Mahana has secured FDA clearance for its pioneering IBS treatment program Mahana IBS, demonstrating its commitment to clinically validated and regulatory-compliant healthcare interventions. Backed by significant venture capital and strategic partnerships, Mahana Therapeutics is expanding its treatment portfolio to address a wider range of chronic conditions, leveraging technology to improve patient outcomes and accessibility to care.
Oaklins’ team in Germany provided comprehensive advisory services to the private shareholder of Cara Care in this transaction.
Contacter l'équipe de la transaction
Kevin Johannes Kambach
Oaklins Germany
Transactions connexes
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
En apprendre plusMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
En apprendre plusGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
En apprendre plus